Smoking behaviour in Swiss schoolchildren: the LuftiBus in the school survey ============================================================================ * Rebeca Mozun * Cristina Ardura-Garcia * Carmen C. M. de Jong * Myrofora Goutaki * Jakob Usemann * Florian Singer * Philipp Latzin * Claudia E. Kuehni * Alexander Moeller ## Abstract **Background** Smoking is a major preventable cause of morbidity and mortality. We assessed smoking behaviour in 6-17-year-olds. In 13-17-year-olds, we studied risk factors for smoking and compared the frequency of respiratory problems between those who smoked and those who did not. **Methods** We used data from *LuftiBus in the school*, a school-based survey of the respiratory health of children carried out 2013-2016 in the canton of Zurich, Switzerland. Participants were asked about cigarette, shisha, and electronic smoking device (ESD) smoking, and respiratory symptoms and diseases. We studied the association between smoking and risk factors using logistic regression. **Results** We included 3488 schoolchildren with data on active smoking. Five percent of the 6-12-year-olds (90 of 1905) had smoked occasionally ( 2. We used the Swiss socioeconomic position index (Swiss-SEP) from the Swiss national cohort as an area-based measure of socioeconomic status17,18. This measure is based on data about rent per square meter, education and occupation of households’ heads, and household crowding, and ranges from 0 (lowest) to 100 (highest)18. We matched the geocodes of the addresses of our participants to the closest geocode of the Swiss socioeconomic position index dataset for the canton of Zurich. If the address or address geocode of a participant was missing, we assigned the mean socioeconomic position index of the participant’s school. The degree of urbanization of the municipality of the schools was categorized as large urban, small urban, or rural area according to the Swiss federal office of statistics classification19. A municipality was categorised as large urban area if at least half of the population lived in high-density clusters, as rural area if more than half of the population lived in rural grid cells, and as small urban area if less than half of the population lived in rural grid cells and less than half lived in a high-density cluster. ### Respiratory symptoms and diseases Information on respiratory symptoms in the past 12 months and respiratory diseases was taken from the children’s questionnaire. We assessed respiratory symptoms in the past 12 months that included cough apart from colds, coughing more than peers, rhinitis apart from colds, a dry mouth when waking-up in the morning as a proxy for nocturnal mouth breathing, dyspnoea, wheeze, and exercise induced wheeze. We also assessed two respiratory diseases, hay fever and having received a diagnosis of asthma from a doctor ever in their life (online E-Table 1 and E-Table 2). ### Statistical analysis We described smoking frequency in the whole study sample of 6–17-year-olds. Frequent smoking started at age 13 or older, so we analysed risk factors and respiratory problems in those aged 13–17 years. We compared proportions of risk factors between categories of frequency of smoking using p-values for a trend for binary and categorical variables and ANOVA for continuous variables. To assess independent effects of risk factors for smoking, we used logistic regression. We selected age, sex, socioeconomic position index, urbanisation, and paternal and maternal smoking a priori as explanatory variables based on the literature4,20,21. in a sensitivity analysis, we also included paternal and maternal education in the model. We studied crude proportions of respiratory symptoms and diseases as reported by the adolescents. In a sensitivity analysis, we also studied the association between respiratory symptoms and frequency of active smoking of any product using logistic regression and adjusting for potential confounders: age, sex, and hay fever or asthma diagnosis. We assumed that reporting of respiratory problems by adolescents is less prone to information bias than reporting by parents since adolescents are probably more aware of their own symptoms, especially during exercise or night time, than their parents. We excluded observations with missing data. Information on missing values can be found in the online material (online E-Table 5). We used the software STATA (Version 14, StataCorp., College Station, TX, USA) for statistical analysis. We used the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines for reporting in cross-sectional studies22. ## Results 3488 participants had consent and information on active smoking of cigarettes, shishas, or ESD. We focused our attention mainly in the subsample of 1583 adolescents (13–17 years), of whom 100 (6%) were obese (Table 1). Most, 912 (58%), lived in small urban areas of the canton of Zurich, and 1140 (87%) were born in Switzerland, although half of their parents originally came from countries other than Switzerland. Mean socioeconomic position index was 64.7 (SD 10.0). The fathers of 467 adolescents (30%) and the mothers of 313 (20%) were current smokers. Maternal smoking during pregnancy was reported by 117 (9%). View this table: [TABLE 1:](http://medrxiv.org/content/early/2020/06/03/2020.05.29.20116525/T1) TABLE 1: Characteristics of participants aged 13 to 17 years by smoking status (N= 1583). ### Use of cigarettes, shishas, and ESDs in the whole study sample Smoking of each product increased with age (Figure 1). In the younger subsample of 612-year-olds (N = 1905), 90 (5%) had smoked any product occasionally. Below the age of 10 years, 14 out of 919 children had smoked (2%). Ten out of 289 children aged 10 years (3%) had smoked, among whom 5 children had smoked cigarettes, 2 ESDs, and 3 shishas. Among 11-year-olds, 17 out of 299 had smoked (6%), 6 of whom had smoked cigarettes, 6 ESDs, and 6 shishas. Among those aged 12 years, 50 out of 398 children (13%) had smoked, 17 of whom had smoked cigarettes, 24 ESDs, and 22 shishas. ![FIGURE 1:](http://medrxiv.org/http://medrxiv.stage.highwire.org/content/medrxiv/early/2020/06/03/2020.05.29.20116525/F1.medium.gif) [FIGURE 1:](http://medrxiv.org/content/early/2020/06/03/2020.05.29.20116525/F1) FIGURE 1: Prevalence of active smoking among adolescents aged 6 to 17 years, stratified by age and sex (N = 3488). Any product: cigarettes, shishas or ESDs. ESDs: electronic smoking devices. Occasional smoking: once-twice or once/week. Whiskers represent 95% confidence intervals. Among adolescents, 966 (61%) had not smoked, 563 (36%) had smoked any product occasionally, and 54 (3%) any product frequently. From age 13 to 15 years, more boys than girls smoked occasionally (42% vs 28%) or frequently (3% vs 1%) (p< 0.01 for the sex difference). However, among 16–17-year-olds, 51% of girls smoked occasionally and 20% frequently, whereas 40% of the boys smoked occasionally and 21% frequently (p = 0.55 for the sex difference). Regarding the type of product smoked, out of the 563 adolescents who smoked occasionally, 414 adolescents (74%) smoked ESDs, 409 (73%) shishas, and 276 (49%) cigarettes. Among the 54 adolescents who smoked frequently, 41 (76%) smoked cigarettes, 11 (20%) ESDs, and 10 (19%) shishas. Adolescents often combined smoking cigarettes, shishas, and ESDs (Figure 2). Among 15–17-year-olds, 121 (25%) had smoked ESDs and cigarettes, 147 (31%) shishas and ESDs, and 104 (22%) had smoked all three. ![FIGURE 2:](http://medrxiv.org/http://medrxiv.stage.highwire.org/content/medrxiv/early/2020/06/03/2020.05.29.20116525/F2.medium.gif) [FIGURE 2:](http://medrxiv.org/content/early/2020/06/03/2020.05.29.20116525/F2) FIGURE 2: Venn diagrams showing the overlap between occasional or frequent active smoking of cigarettes, shishas and electronic smoking devices in adolescents aged (a) 13–14 and (b) 15–17 years. ESDs: electronic smoking devices. ### Sociodemographic risk factors for adolescent active smoking of any product Participants who reported any smoking more often were male (adjusted odds ratio 2.1 95% confidence interval 1.7 – 2.6), older (aOR 2.0 per year increase of age, 95% Cl 1.8 – 2.3), and had a mother (aOR 1.7, 95% Cl 1.3 – 2.3) or father (aOR 1.5, 95% Cl 1.2 – 1.9) who smoked (Figure 3, online E-Table 4). Any smoking was more common in rural (aOR 1.8, 95% Cl 1.2 – 2.9) and large urban areas (aOR 1.2, 95% Cl 0.9–1.6) than in small urban areas. We found no association with socioeconomic position index (aOR 1.0 per decile increase, 95% Cl 0.9 –1.1), or with paternal and maternal education (online ETable 5). ![FIGURE 3:](http://medrxiv.org/http://medrxiv.stage.highwire.org/content/medrxiv/early/2020/06/03/2020.05.29.20116525/F3.medium.gif) [FIGURE 3:](http://medrxiv.org/content/early/2020/06/03/2020.05.29.20116525/F3) FIGURE 3: Unadjusted (circle) and adjusted (triangle) odds ratios for the association between sociodemographic factors and adolescent reported occasional or frequent smoking (N = 1527). The adjusted model includes all the variables in the figure. A table with the adjusted and unadjusted odds ratios and confidence intervals can be found in the supplementary material (E-Table 4). ### Respiratory symptoms in adolescents by frequency of active smoking of any product Smokers had more respiratory symptoms in the past 12 months than nonsmokers, even if the smoking was only occasional (Table 2). This was also true when adjusting for potential confounders, with similar point estimates when adjusting for age, sex, and asthma or hay fever, and also when adjusting for paternal and maternal smoking (online E-Table 6). Upper airway respiratory symptoms were more common among adolescents who smoked. Rhinitis apart from colds was more often reported by frequent smokers (44%) and occasional smokers (32%) than by never smokers (29%). Similarly, 17% of adolescents who smoked frequently had a dry mouth when waking up, as did 13% of those who smoked occasionally and 9% of nonsmokers. Rhinitis apart from colds and having a dry mouth when waking up were more common in occasional smokers (aOR for rhinitis 1.1, 95% Cl 0.9–1.4; aOR for dry mouth 1.6, 95% Cl 1.1–2.3,) and frequent smokers (aOR for rhinitis 1.9, 95% Cl 1.1–3.5; aOR for dry mouth 2.6, 95% Cl 1.2–5.8) than in never smokers adjusting for age, sex, and hay fever. View this table: [TABLE 2:](http://medrxiv.org/content/early/2020/06/03/2020.05.29.20116525/T2) TABLE 2: Self-reported respiratory symptoms and diseases in adolescents aged 13–17 years by frequency of self-reported smoking of any type. Lower airway respiratory symptoms were also more frequent among smokers. Wheeze was more common in frequent (12%) or occasional smokers (13%) than in never smokers (8%). Adolescents reported exercise-triggered wheeze more frequently than wheeze, and exercise-triggered wheeze was also more common in frequent (22%) or occasional smokers (17%), than in never smokers (12%). Similarly, dyspnoea was more often reported by frequent (30%) and occasional (22%) smokers than never smokers (19%). When adjusting for age, sex, and asthma diagnosis, when compared to never smokers occasional smokers had more wheeze (aOR 2.1, 95% Cl 1.5–3.1), exercise induced wheeze (aOR 1.9, 95% Cl 1.3–2.6) and dyspnoea (aOR 1.4, 95% Cl: 1.0–1.8). The adjusted odds of wheeze were twice as high in frequent smokers compared to never smokers (aOR 2.0, 95% Cl 0.8 – 5.4), exercise induced wheeze (aOR 3.2, 95% Cl 1.5–6.7), and dyspnoea (aOR 2.2, 95% Cl 1.1–4.5). Compared to never smokers, adolescents tended to have more cough apart from colds if they smoked occasionally (aOR 1.3, 95% Cl 1.0–1.7) or frequently (aOR 1.7, 95% Cl 0.9–3.2), and to cough more if they smoked occasionally (aOR 1.4, 95% Cl 0.8–2.4) or frequently (aOR 3.0, 95% Cl 0.9–9.5), adjusting for confounders. ## Discussion A significant proportion of adolescents smoked and often combined smoking cigarettes, shishas, and ESDs. Occasional smoking of shishas and ESDs was more popular than smoking cigarettes. Most of those who smoked frequently were 16–17 years old and smoked cigarettes, which could reflect higher nicotine dependency. More adolescents who smoked had a mother or father who smoked. Adolescents who smoked frequently or occasionally had more respiratory symptoms in the past 12 months including rhinitis apart from colds, a dry mouth when waking up in the morning, dyspnoea, and wheeze and exercise induced wheeze than never smokers. ### Strengths and limitations The school-based settings in which we collected information using structured questionnaires with validated questions on respiratory problems are ideal for studying smoking behaviour in school-aged children. School directors decided whether to participate in the study and with which classes, independently of the smoking status of the students, which may have reduced selection bias. Still, our sample was not randomly selected and may not be representative of the whole population of school-aged children living in the canton of Zurich. We did not objectively assess nicotine consumption by cotinine measurements, and response bias could have led to an underestimation of smoking among adolescents. However, we believe that response bias may have been reduced by children’s answers not being available to their parents. We did not collect information on brand names or composition of ESDs smoked, and future studies should collect this information to allow more specific consumption monitoring and health risk assessments9. ### Comparison with previous studies Smoking was common among adolescents in our study. Prevalence of frequent smoking of cigarettes in Switzerland was lower than in Germany, Italy, and France, but higher than in Denmark, England, and Sweden according to reports of the Health Behaviour in School aged Children (HBSC) surveys23. Similarly, prevalence of cigarette smoking in Swiss adults seems below the European average24,25. However, Jakob et al. showed that the cigarette consumption estimated by aggregate sales data is larger than survey-based estimates for Switzerland24. In that study, the discrepancy between actual and reported cigarette consumption was higher in Switzerland (46%) than France (7%). Underreporting could be a reason why smoking prevalence seems to be relatively low in Switzerland despite its loose tobacco regulation. The US national tobacco surveys showed that the prevalence of ESD use in the past 30 days increased while cigarette smoking decreased between 2011–2018 among high school students aged 13–17 years6. The marked increase in use of ESDs among high school students in the US coincided with a steep increase in the sales of certain ESD brands that are now also available in the Swiss market6”8. Studies of ESD and shisha use in European adolescents report different prevalence measures, include different age groups, and were done in different years making comparison between countries challenging. Paternal and maternal smoking were independently associated with active smoking among adolescents in our study. This is in line with previous studies20,26. A study from Germany found that parental cigarette smoking was a risk factor for ESD smoking in adolescents21. Peer behaviour also plays an important role in adolescent smoking behaviour20,21.Adolescents living in rural areas smoked more often than those in urban areas independently of their family’s socioeconomic position and parental smoking status. A recent study from the US reported a smaller reduction in the prevalence of adolescent cigarette smoking in rural than in urban areas, implying that preventive strategies may be less strict in those areas28. Social drivers of ESD and shisha smoking and their relationship with cigarette smoking deserve further investigation9. Smoking any product was associated with respiratory symptoms in our study, even if the smoking was occasional. A study in adolescents from Chile also showed that frequent active smoking of cigarettes is associated with respiratory symptoms29. A large population-based cohort study from the US found significant decline in lung function even among light adult cigarette smokers30. Population-based surveys in Asia and North America also found increased risks of upper and lower respiratory symptoms among adolescents who smoke ESDs10,31”33. McConnell et al. found higher risk of chronic cough and bronchitis among adolescents who had smoked ESDs even after adjusting for potential confounders31. ### Implications for public health and for research Use of ESDs by adolescents is not safe and can have adverse consequences for personal and public health34. With or without nicotine, ESDs expose the respiratory airways to toxic and irritating agents such as propylene glycol, glycerol, and flavourings. ESDs smoking affects nasal and bronchial epithelia by impairing ciliary function and altering gene expression10. Furthermore, a recent meta-analysis showed that adolescents and young adults who had smoked ESDs ever in their life were subsequently more likely to start smoking cigarettes than those who had never smoked ESDs (pooled aOR 3.5, 95% Cl 2.4 – 5.2)11 We need to protect adolescents from every type of smoking, and this may require adapting preventive policies. Switzerland signed the WHO framework convention on tobacco control in 2004, but has still not ratified it35. Swiss preventive strategies that involve regulation of tobacco affordability, advertising, and smoking in public spaces are less strict than those of other European countries24. Exposure to tobacco advertising, in particular, has been shown to increase the likelihood of smoking initiation among adolescents8,36,37. Currently, marketing of ESD brands often targets adolescents by advertising through social media and offering a variety of candy flavours28. Regulation of ESDs was absent in Switzerland and sales were free of age limitation during our study9, though this is likely to change in coming years due to new federal legislation currently under study. The need as well to regulate quality control of the ingredients and flavouring of ESDs has been highlighted by research13. The composition of ESDs varies greatly, and lung injury associated with ESDs containing tetrahydrocannabinol caused several deaths in the US38. Yet in spite of harms already documented, the long-term effects of ESD smoking on lung function and the full range of associated respiratory symptoms are unclear and require further research10. ## Conclusion Occasional smoking of shishas and ESDs is popular among Swiss adolescents, who often combine smoking shishas, ESDs, and cigarettes. We encourage structural preventive strategies that focus not only on traditional cigarettes, but also on shishas and ESDs. ## Data Availability The LuftiBus in the school dataset is available on reasonable request by contacting Alexander Moeller by email: alexander.moeller{at}kispi.uzh.ch ## Author contributions Alexander Moeller, Claudia E. Kuehni and Philipp Latzin conceptualised and designed the study. Alexander Moeller supervised data collection. Rebeca Mozun analysed the data and drafted the manuscript. Cristina Ardura-Garcia, Carmen C. M. de Jong, Myrofora Goutaki, Jakob Usemann and Florian Singer supported the statistical analysis and gave input for interpretation of the data. All authors critically revised and approved the manuscript. ## Funding Lunge Zurich, Switzerland. ## Acknowledgements We thank schools, children and their families for taking part in the study. We thank fieldworkers of the LuftiBus in the school study for their technical support during the study. We thank Christopher Ritter (Institute of Social and Preventive Medicine, University of Bern) for his editorial contributions. * Received May 29, 2020. * Revision received May 29, 2020. * Accepted June 3, 2020. * © 2020, Posted by Cold Spring Harbor Laboratory This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/) ## REFERENCE 1. 1.GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885–1906. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(17)30819-X&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=28390697&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F03%2F2020.05.29.20116525.atom) 2. 2.Mattli R, Farcher R, Dettling M, Syleouni M-E, Wieser S. Die Krankheitslast des Tabakkonsums in der Schweiz: Schätzung für 2015 und Prognose bis 2050. In. Winterthur: Zürcher Hochschule für angewandte Wissenschaften; 2019. 3. 3.Swiss Federal Office of Health. Addition Monitoring in Switzerland. [www.suchtmonitoring.ch](http://www.suchtmonitoring.ch). Accessed March 1, 2020. 4. 4.Gmel G, Kuendig H, Notari L, Gmel C. Suchtmonitoring Schweiz – Konsum von Alkohol, uchtmonitoring Schweiz – Konsum von Alkohol Tabak und illegalen Drogen in der Schweiz im Jahr 2016. Sucht Schweiz, Lausanne, Schweiz. 2017. 5. 5.Delgrande Jordan M, Schneider E, Eichenberger Y, Kretschmann A. La consommation de substances psychoactives des 11 à 15 ans en Suisse – Situation en 2018 et évolutions depuis 1986 – Résultats de l’étude Health Behaviour in School-aged Children (HBSC) (rapport de recherche No 100). 2019. 6. 6.Gentzke AS, Creamer M, Cullen KA, Ambrose BK, Willis G, Jamal A, King BA. Vital Signs: Tobacco Product Use Among Middle and High School Students – United States, 2011–2018. MMWR Morbidity and mortality weekly report. 2019;68(6):157–164. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.15585/mmwr.mm6806e1&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=30763302&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F03%2F2020.05.29.20116525.atom) 7. 7.King BA, Gammon DG, Marynak KL, Rogers T. Electronic Cigarette Sales in the United States, 2013–2017. JAMA. 2018;320(13):1379–1380. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jama.2018.10488&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=30285167&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F03%2F2020.05.29.20116525.atom) 8. 8.Huang J, Duan Z, Kwok J, Binns S, Vera LE, Kim Y, Szczypka G, Emery SL. Vaping versus J U U Ling: how the extraordinary growth and marketing ofJUUL transformed the US retail e-cigarette market. Tob Control. 2019;28(2):146–151. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTQ6InRvYmFjY29jb250cm9sIjtzOjU6InJlc2lkIjtzOjg6IjI4LzIvMTQ2IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMDYvMDMvMjAyMC4wNS4yOS4yMDExNjUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 9. 9.Bals R, Boyd J, Esposito S, Foronjy R, Hiemstra PS, Jimenez-Ruiz CA, Katsaounou P, Lindberg A, Metz C, Schober W, et al. Electronic cigarettes: a task force report from the European Respiratory Society. Eur RespirJ. 2019;53(2). 10. 10.Gotts JE, Jordt SE, McConnell R, Tarran R. What are the respiratory effects of e-cigarettes? BMJ. 2019;367. 11. 11.Soneji S, Barrington-Trimis JL, Wills TA, Leventhal AM, Unger JB, Gibson LA, Yang J, Primack BA, Andrews JA, Miech RA, et al. Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults: A Systematic Review and Meta-analysis. JAMA Pediatr. 2017;171(8):788–797. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F03%2F2020.05.29.20116525.atom) 12. 12.Kuehni CE, Barben J. Protecting children from second-hand smoke. Eur RespirJ. 2015;46(3):601–603. 13. 13.Ferkol TW, Farber HJ, La Grutta S, Leone FT, Marshall HM, Neptune E, Pisinger C, Vanker A, Wisotzky M, Zabert GE, et al. Electronic cigarette use in youths: a position statement of the Forum of International Respiratory Societies. Eur RespirJ. 2018;51(5). 14. 14.Kuehni CE, Brooke AM, Strippoli MP, Spycher BD, Davis A, Silverman M. Cohort profile: the Leicester respiratory cohorts. Int J Epidemiol. 2007;36(5):977–985. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/ije/dym090&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17911154&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F03%2F2020.05.29.20116525.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000250680900011&link_type=ISI) 15. 15.Asher Ml, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, Mitchell EA, Pearce N, Sibbald B, Stewart AW, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur RespirJ. 1995;8(3):483–491. 16. 16.Braegger C, Jenni O, Konrad D, Molinari L. Neue Wachstumskurven für die Schweiz. Paediatrica. 2011;Vol 22 nl. 17. 17.Bopp M, Spoerri A, Zwahlen M, Gutzwiller F, Paccaud F, Braun-Fahrlander C, Rougemont A, Egger M. Cohort Profile: the Swiss National Cohort--a longitudinal study of 6.8 million people. Int J Epidemiol. 2009;38(2):379–384. 18. 18.Panczak R, Galobardes B, Voorpostel M, Spoerri A, Zwahlen M, Egger M. A Swiss neighbourhood index of socioeconomic position: development and association with mortality. Journal of epidemiology and community health. 2012;66(12): 1129–1136. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiamVjaCI7czo1OiJyZXNpZCI7czoxMDoiNjYvMTIvMTEyOSI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIwLzA2LzAzLzIwMjAuMDUuMjkuMjAxMTY1MjUuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 19. 19.Swiss Federal Office of Statistics. Räumliche Gliederungen. [https://www.bfs.admin.ch/bfs/de/home/statistiken/querschnittsthemen/raeumliche-analysen/raeumliche-gliederungen.html](https://www.bfs.admin.ch/bfs/de/home/statistiken/querschnittsthemen/raeumliche-analysen/raeumliche-gliederungen.html) 20. 20.Laverty AA, Filippidis FT, Taylor-Robinson D, Millett C, Bush A, Hopkinson NS. Smoking uptake in UK children: analysis of the UK Millennium Cohort Study. Thorax. 2019;74(6):607–610. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToidGhvcmF4am5sIjtzOjU6InJlc2lkIjtzOjg6Ijc0LzYvNjA3IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMDYvMDMvMjAyMC4wNS4yOS4yMDExNjUyNS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 21. 21.Pfortner TK, De Clercq B, Lenzi M, Vieno A, Rathmann K, Moor I, Hublet A, Molcho M, Kunst AE, Richter M. Does the association between different dimension of social capital and adolescent smoking vary by socioeconomic status? a pooled cross-national analysis. IntJ Public Health. 2015;60(8):901–910. 22. 22.von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Journal of clinical epidemiology. 2008;61(4):344–349. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jclinepi.2007.11.008&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=18313558&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F03%2F2020.05.29.20116525.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000253998200007&link_type=ISI) 23. 23.WHO. HBSC international report: Growing up unequal. 2016. 24. 24.Jakob J, Cornuz J, Diethelm P. Prevalence of tobacco smoking in Switzerland: do reported numbers underestimate reality? Swiss Med Wkly. 2017;147:wl4437. 25. 25.Joossens L, Raw M. The Tobacco Control Scale 2013 in Europe. A report of the Association of European Cancer Leagues. 2014. 26. 26.Selya AS, Dierker LC, Rose JS, Hedeker D, Mermelstein RJ. Risk factors for adolescent smoking: parental smoking and the mediating role of nicotine dependence. Drug Alcohol Depend. 2012;124(3):311–318. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.drugalcdep.2012.02.004&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=22365898&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F03%2F2020.05.29.20116525.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000307324400019&link_type=ISI) 27. 27.Hanewinkel R, Isensee B. Risk factors for e-cigarette, conventional cigarette, and dual use in German adolescents: a cohort study. Prev Med. 2015;74:59–62. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.ypmed.2015.03.006&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=25770433&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F03%2F2020.05.29.20116525.atom) 28. 28.Ziller EC, Lenardson JD, Paluso NC, Talbot JA, Daley A. Rural-Urban Differences in the Decline of Adolescent Cigarette Smoking. Am J Public Health. 2019;109(5):771–773. 29. 29.Mallol J, Castro-Rodriguez JA, Cortez E. Effects of active tobacco smoking on the prevalence of asthma-like symptoms in adolescents. International journal of chronic obstructive pulmonary disease. 2007;2(1):65–69. 30. 30.Oelsner EC, Balte PP, Bhatt SP, Cassano PA, Couper D, Folsom AR, Freedman ND, Jacobs DR, Jr., Kalhan R, Mathew AR, et al. Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study. The Lancet Respiratory medicine. 2020;8(1):34–44. 31. 31.McConnell R, Barrington-Trimis JL, Wang K, Urman R, Hong H, Unger J, Samet J, Leventhal A, Berhane K. Electronic Cigarette Use and Respiratory Symptoms in Adolescents. Am J Respir Crit Care Med. 2017;195(8):1043–1049. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1164/rccm.201604-0804OC&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=27806211&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F03%2F2020.05.29.20116525.atom) 32. 32.Wang MP, Ho SY, Leung LT, Lam TH. Electronic Cigarette Use and Respiratory Symptoms in Chinese Adolescents in Hong Kong. JAMA Pediatr. 2016;170(1):89–91. 33. 33.Cho JH, Paik SY. Association between Electronic Cigarette Use and Asthma among High School Students in South Korea. PLoS One. 2016;11 (3):e0151022. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pone.0151022&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=26942764&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F03%2F2020.05.29.20116525.atom) 34. 34.Pisinger C, Dagli E, Filippidis FT, Hedman L, Janson C, Loukides S, Ravara S, Saraiva I, VestboJ. ERS and tobacco harm reduction. Eur Respir J. 2019;54(6). 35. 35.World Health Organization. WHO Framework Convention on Tobacco Control. World Health Assembly, 56. 2003; [https://apps.who.int/iris/handle/10665/78302](https://apps.who.int/iris/handle/10665/78302). 36. 36.Lovato C, Watts A, Stead LF. Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours. Cochrane Db Syst Rev. 2011(10). 37. 37.Fadus MC, Smith TT, Squeglia LM. The rise of e-cigarettes, pod mod devices, and JUUL among youth: Factors influencing use, health implications, and downstream effects. Drug Alcohol Depend. 2019;201:85–93. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F03%2F2020.05.29.20116525.atom) 38. 38.Perrine CG, Pickens CM, Boehmer TK, King BA, Jones CM, DeSisto CL, Duca LM, Lekiachvili A, Kenemer B, Shamout M, et al. Characteristics of a Multistate Outbreak of Lung Injury Associated with E-cigarette Use, or Vaping – United States, 2019. MMWR Morbidity and mortality weekly report. 2019;68(39):860–864. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.15585/mmwr.mm6839e1&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F03%2F2020.05.29.20116525.atom)